상세 보기

Gemigliptin added to ongoing metformin therapy provides sustained glycaemic control over 52 weeks and was well tolerated in patients with type 2 diabetes

Rhee, E. J.;
Min, K. W.;
Jang, H. C.;
Chung, C. H.;
Nam-Goong, I. S.;
... Baik, S. H.;
외 9명

제목: Gemigliptin added to ongoing metformin therapy provides sustained glycaemic control over 52 weeks and was well tolerated in patients with type 2 diabetes

저자: Rhee, E. J.; Min, K. W.; Jang, H. C.; Chung, C. H.; Nam-Goong, I. S.; Bae, H. Y.; Baik, S. H.; Shivane, V. K.; Sosale, A. R.; Dharmalingam, M.; Gandhi, P.; Gupta, S. K.; Ahn, J. Y.; Bang, K. S.; Lee, M. K.

DOI: 10.1007/s00125-013-3012-z

발행일: 2013-09

학회명: 49th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD)

개최지: Barcelona, SPAIN

개최국가: 미국

학회 개최일: 2013-09-23 ~ 2013-09-27

언어: ENG